Nitroglycerin and Ifosfamide drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Nitroglycerin (nitroglycerin) and Ifosfamide (ifosfamide). Common drug interactions include encephalopathy among females and status epilepticus among males.

The phase IV clinical study analyzes what interactions people have when they take Nitroglycerin and Ifosfamide. It is created by eHealthMe based on reports of 11 people who take the same drugs from the FDA, and is updated regularly.

What is Nitroglycerin?

Nitroglycerin has active ingredients of nitroglycerin. It is often used in chest pain. eHealthMe is studying from 52,884 Nitroglycerin users. Check the latest studies of Nitroglycerin.

What is Ifosfamide?

Ifosfamide has active ingredients of ifosfamide. eHealthMe is studying from 21,285 Ifosfamide users. Check the latest studies of Ifosfamide.



On Jul, 31, 2026

11 people who take Nitroglycerin and Ifosfamide together, and have interactions are studied.

Nitroglycerin and Ifosfamide drug interactions.

What are the common drug interactions of Nitroglycerin and Ifosfamide, by gender? *:

female:

  1. Encephalopathy (functioning of the brain is affected by some agent or condition)
  2. Multi-organ failure (multisystem organ failure)
  3. Neutropenic sepsis (whole body infection is caused by a condition in which the number of white blood cells (called neutrophils) in the blood is low. neutrophils help the body to fight infection)

male:

  1. Status epilepticus (a life-threatening condition in which the brain is in a state of persistent seizure)
  2. Acute myocardial infarction (acute heart attack)
  3. Dehydration (dryness resulting from the removal of water)
  4. Depressed level of consciousness
  5. Diarrhoea
  6. Diffuse large b-cell lymphoma (cancer of b cells, a type of white blood cell)
  7. Disease progression
  8. Drug ineffective
  9. Electrolyte imbalance
  10. General physical health deterioration (weak health status)

What are the common drug interactions of Nitroglycerin and Ifosfamide, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Acute respiratory distress syndrome
  2. Creatine urine increased
  3. General physical health deterioration (weak health status)
  4. Lung infiltration (a substance that normally includes fluid, inflammatory exudates or cells that fill a region of lung)
  5. Pneumonitis (inflammation of the walls of the alveoli in the lungs)
  6. Reperfusion injury (tissue damage caused when blood supply returns to the tissue after a period of ischemia or lack of oxygen)
  7. Respiratory failure (inadequate gas exchange by the respiratory system)
  8. Shock (a life-threatening condition with symptoms like low blood pressure, weakness, shallow breathing, cold, clammy skin)
  9. Tumour marker increased
  10. Urine output decreased

30-39:

n/a

40-49:

n/a

50-59:

  1. Status epilepticus (a life-threatening condition in which the brain is in a state of persistent seizure)
  2. Encephalopathy (functioning of the brain is affected by some agent or condition)
  3. Multi-organ failure (multisystem organ failure)
  4. Neutropenic sepsis (whole body infection is caused by a condition in which the number of white blood cells (called neutrophils) in the blood is low. neutrophils help the body to fight infection)

60+:

  1. Acute myocardial infarction (acute heart attack)
  2. Anorexia (eating disorder characterized by immoderate food restriction and irrational fear of gaining weight)
  3. Diffuse large b-cell lymphoma (cancer of b cells, a type of white blood cell)
  4. Disease progression
  5. Drug ineffective
  6. Electrolyte imbalance
  7. Hepatocellular damage (liver damage)
  8. Nausea (feeling of having an urge to vomit)
  9. Neoplasm progression (growth of tumour)
  10. Nephropathy (damage to or disease of a kidney)

What are the existing conditions these people have? *

  1. Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 6 people, 54.55%
  2. Testicular Germ Cell Cancer (germ cell cancer of testes): 1 person, 9.09%
  3. Non-Hodgkin's Lymphoma Recurrent (reoccurrence malignant (cancer) cells form in the lymph system): 1 person, 9.09%
  4. Lymphoma (cancer that begins in immune system cells): 1 person, 9.09%
  5. Infusion Related Reaction: 1 person, 9.09%
  6. Hypotension (abnormally low blood pressure): 1 person, 9.09%
  7. Hiv Test Positive: 1 person, 9.09%
  8. Fever: 1 person, 9.09%
  9. Femur Fracture: 1 person, 9.09%
  10. Diffuse Large B-Cell Lymphoma Stage Iv (cancer of b cells, a type of white blood cell-stage iv): 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Nitroglycerin and Ifosfamide?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Nitroglycerin and Ifosfamide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Nitroglycerin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Ifosfamide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Nitroglycerin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ifosfamide and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on nitroglycerin and ifosfamide (the active ingredients of Nitroglycerin and Ifosfamide, respectively), and Nitroglycerin and Ifosfamide (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: